PET-CT limited is a diagnostic imaging test that combines two imaging techniques: positron emission tomography (PET) and computed tomography (CT). The combination of PET and CT allows for more precise localization of metabolic activity within the body.
The clinical uses of PET-CT limited are varied and depend on the reason for the test. In a LIMITED test, a specific part of the body is examined rather than the whole body.This test is commonly used in oncology to detect and stage various types of cancer, including lung cancer, lymphoma, and colorectal cancer. PET-CT limited can also be used to monitor the effectiveness of cancer treatment by evaluating changes in metabolic activity over time.
PET-CT limited can also be used to evaluate other conditions, such as infections and inflammation in the body, including osteomyelitis and sarcoidosis. Additionally, PET-CT limited can be used to evaluate the blood flow and function of the heart, which can help diagnose heart conditions such as coronary artery disease.
Overall, PET-CT limited is a valuable tool for healthcare professionals in the diagnosis and management of various conditions. It provides detailed information about the metabolic activity and structures of the body's tissues and organs, which can help guide treatment decisions and improve patient outcomes.